Related Experiment Videos
Specific endonucleolytic cleavage of IGF-II mRNAs
D Meinsma1, P E Holthuizen, J L Van den Brande
1Wilhelmina Childrens Hospital, Utrecht, The Netherlands.
Abstract:
Expression of the human insulin-like growth factor II (IGF-II) gene gives rise to a family of mRNAs which are expressed in a tissue- and developmental-specific manner. Recently, an IGF-II RNA species of 1.8 kb was detected which consists of the 3' terminal untranslated region of the last IGF-II exon. We have investigated the mechanism of formation of this RNA employing IGF-II minigenes. Analysis of the expression of these genes has revealed that the 1.8-kb RNA does not result from transcription activation, but arises by specific cleavage of IGF-II transcripts.
Insights
Researchers explored the origin of a specific 1.8 kb human insulin-like growth factor II (IGF-II) RNA. They found this RNA arises from specific cleavage of IGF-II transcripts, not transcription activation.
Area of Science:
- Molecular Biology
- Genetics
- RNA Biology
Background:
- The human insulin-like growth factor II (IGF-II) gene produces various messenger RNA (mRNA) molecules.
- These IGF-II mRNAs exhibit tissue-specific and developmental-specific expression patterns.
- A distinct 1.8 kb IGF-II RNA species, comprising the 3' untranslated region of the final IGF-II exon, was recently identified.
Purpose of the Study:
- To investigate the formation mechanism of the 1.8 kb IGF-II RNA species.
- To determine if the 1.8 kb RNA results from transcription activation or post-transcriptional processing.
Main Methods:
- Utilized IGF-II minigenes to study RNA expression.
- Analyzed the expression patterns of these minigenes.
Main Results:
- The 1.8 kb IGF-II RNA does not originate from transcription activation.
- This specific RNA species is generated through a process of precise cleavage of IGF-II transcripts.
Conclusions:
- The formation of the 1.8 kb IGF-II RNA is a result of specific post-transcriptional cleavage.
- This finding clarifies the biogenesis of a particular IGF-II mRNA variant.